Korsana Biosciences’ preclinical Alzheimer’s disease drug comes from a platform technology that enables antibodies to cross the blood-brain barrier. Roche and AbbVie have clinical-stage drugs taking a similar approach to Alzheimer’s. The post Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug appeared first on MedCity News.
By KIM BELLARD I’d love to be writing about something fun. Something that makes us think about things in a new way, or something exciting that will take us into the future. There are lots of such things happening, but there’s too many Orwellian actions happening that I can’t be silent about. Diversity, we’re told,…
United Healthcare’s shocking quarterly earnings miss, a new regular feature on the Trump administration’s healthcare moves, and the future of value-based care. That’s the focus of the latest episode of the Debunked podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 15: How Did…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
The post Why Cheaper Sugary Drinks & Alcohol Are Increasing Diseases | Medifyhome appeared first on Medifyhome.
Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after the same target. Biologics are a new treatment option for COPD following approvals of antibodies from Sanofi and GSK. The post Roche Reports Mixed Data…
Bain Capital Private Equity led Kailera Therapeutics’ Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly’s blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera’s pipeline. The post Kailera Secures…
Even top companies struggle to maintain adequate IT staffing levels. Here are several reasons why FQHCs should consider outsourcing to a firm experienced in the nuances of healthcare. The post Why Outsourcing IT and Cybersecurity is the Smart Choice for FQHCs appeared first on MedCity News.
ASTP is working with stakeholders to develop the next generation of FHIR capabilities such as a standard approach to enable writing health information from external sources into the patient health record
En el Valle de San Luis, al sur de Colorado, las nubes se elevan sobre las imponentes montañas de la cordillera Sangre de Cristo. Un coro de mirlos gorjea mientras revolotea entre los juncos de un refugio de vida silvestre. Grandes campos cultivados en forma de círculo, intercalados con arbustos autóctonos, dan una sensación de…